Antitumor effects of residual tumor after cryoablation: the combined effect of residual tumor and a protein-bound polysaccharide on multiple liver metastases in a murine model☆
Introduction
The treatment of malignant tumors by cryoablation has attracted attention because of its low invasiveness and relatively low cost. Considerable therapeutic effects on metastatic liver tumors [2], [16] and prostatic cancer [6], [15] have been reported. Cryoablation may not only destroy tumor directly by freezing and thawing, but may also induce a specific anti-tumor effect by an immune mechanism that is stimulated by tumor antigens released by the cryonecrotic tissue [1], [18]. Thus, cryoablation may be particularly promising in the treatment of advanced cancer with distant metastasis. However, it was observed in Japan from the late 1970s that cryosurgical treatment of tumors could have the negative effect of enhancing the growth of residual tumors and the method became less popular [5], [21]. This phenomenon was named high-zone tolerance.
We considered the possibility that the tumor enhancement and reduced survival might be induced by sensitization caused by a large amount of frozen and thawed tissue. We studied a metastatic liver tumor model in mice that was produced by the intrasplenic inoculation of colon 26 cells into BALB/c mice and we reported the preventative effects of biological response modifiers such as the protein-bound polysaccharide preparation we have called Krestin [19]. In the present study, we investigated the anti-tumor effect of cryoablation by a contact method on metastatic liver tumors and we discuss the mechanism underlying tumor enhancement and the preventative effects of Krestin.
Section snippets
Experimental animals and tumor
Six-week-old male BALB/c mice and the mouse colon cancer cell line, colon 26 were used. There were five mice in each group.
Tumor inoculation
Under ether anesthesia the spleen was transposed to a subcutaneous pouch and a metastatic tumor was induced by injection of 1×105 colon 26 cells into the inferior border of the spleen.
Cryoablation against metastatic liver tumors
Fourteen days after inoculation of the tumor cells, laparotomy was performed by subcostal skin incision and mice having about six visible nodules over 1 mm in diameter were selected for the
Number of metastatic liver nodules
When mice were killed on day 14 after cryoablation, there was no gross evidence of tumor growth or of persistence around the frozen lesions, and slight scar formation was observed. The number of metastatic liver nodules in the SV group was significantly lower (13.2±1.3) than those in the control group (p<0.05) and the LV group (p<0.05).
The LV group showed the highest number, but there was no statistically significant difference between the LV group and the controls. On the other hand, in the
Discussion
We have previously studied immune responses following tumor cryoablation by examining morphological changes in regional lymph nodes [8] and the effects of serum obtained after cryoablation on rat lymphoblasts that had been induced by PHA [12] or Con A [13]. We observed that some types of tumor-specific anti-tumor immune response were enhanced in regional lymph node lymphocytes obtained after cryoablation when they were evaluated by measuring cytotoxic activity and/or lymphocyte subsets [10].
Conclusions
A BALB/c mouse model of metastatic liver cancer was produced by the intrasplenic inoculation of colon-26 cells. This model was used to examine the anti-tumor effect of cryoablation by the contact method and to compare its usefulness in combination with Krestin to prevent the high zone tolerance induced by massive freezing. The production of cytokines and NK or CTL activity of splenocytes were measured. The results suggest that Krestin improves the cytokine balance and shows an anti-tumor effect
References (21)
- et al.
Prospects for cryo-immunotherapy in cases of metastasizing carcinoma of the prostate
Cryobiology
(1971) - et al.
A comparative laboratory study of liquid nitrogen and argon gas cryosurgery systems
Cryobiology
(1997) - et al.
Serum response of hepatocyte growth factor, insulin-like growth factor-1, interleukin-6, and acute phase proteins in patients with colorectal liver metastases treated with partial hepatectomy or cryosurgery
J. Hepatol.
(2001) - et al.
Direct action of a protein-bound polysaccharide, PSK, on transforming growth factor-β
Immunopharmacology
(1998) - et al.
Immunological response of regional lymph nodes after tumor cryosurgery: experimental study in rats
Cryobiology
(1986) - et al.
Cryosurgical ablation of renal tumors using 1.5-mm, ultrathin cryoprobes
Urology
(2002) - et al.
Reduction in recurrence risk for involved or inadequate margins with edge cryotherapy after liver resection for colorectal metastases
Arch. Surg.
(2001) - et al.
Specific immunotherapy with tumor specific antigens
Jpn. J. Cancer Clin.
(1978) - et al.
Cryosurgical ablation for prostate cancer: preliminary results of a new advanced technique
Isr. Med. Assoc. J.
(2001) - et al.
Experimental studies on cryosurgery and cryoimmunity in rats using metastasizing rat’s mammary tumor, MRMT-1
J. Low Temp. Med.
(1982)
Cited by (0)
- ☆
This work was funded by institutional sources.